NetworkNewsBreaks

ThursdayDec 04, 2025 3:02 pm

NetworkNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Focuses on Critical Mineral Supply with Cutting-Edge Technology

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) was featured in a recent publication that discussed its positioning amid a new kind of energy crisis — and it’s not oil or gas. The piece reads, “A recent TIME article warns that governments must act now to stave off damaging disruptions to industries from power grids to jet engines, arguing that the same international playbook forged after the 1973 oil crisis must be applied to critical minerals today. In that context, Ucore Rare Metals is advancing U.S.-based rare earth separation capacity…

Continue Reading

ThursdayDec 04, 2025 2:30 pm

NetworkNewsBreaks – BluSky AI Inc. (BSAI) Pushing the Boundaries of AI Infrastructure with Neocloud and SkyMod Technology

As tech giants pour billions into traditional data center expansion, BluSky AI (OTC: BSAI) is uniquely positioned with its innovative Neocloud platform and modular SkyMod technology. “BluSky AI is focused to democratize access to enterprise-grade AI infrastructure through a fundamentally different approach, delivering compute power in months rather than years,” reads a recent article. “BluSky AI’s trajectory starts with its revolutionary Neocloud platform, built for AI from the ground up. BluSky AI’s initial Neocloud will consist of 150 MW with 20 planned locations spread across the U.S. With locations from 9 MW to 50 MW located closer to businesses to facilitate low…

Continue Reading

ThursdayDec 04, 2025 1:40 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast

CNS Pharmaceuticals (NASDAQ: CNSP) was featured in a BioMedWire Podcast discussing its sharpened focus on glioblastoma multiforme (“GBM”), one of the deadliest and least treatable forms of cancer. In the interview, CEO John Climaco said of GBM, “Patients have very little hope. Our mission is to change that completely, and we think we have the drugs to do it.” An article discussing this reads, “The company’s therapeutic strategy centers on overcoming the blood-brain barrier (‘BBB’), a critical biological defense that restricts most drugs from reaching brain tumors. ‘The problem for patients and clinicians in the space is that the cancers take…

Continue Reading

ThursdayDec 04, 2025 1:09 pm

NetworkNewsBreaks – Parler Technologies, Inc. Launches Regulation D 506(c) Offering Ahead of Planned 2026–2027 Uplisting

Parler Technologies has initiated a Regulation D, Rule 506(c) private placement to raise up to $50 million, with the option to increase to $100 million, ahead of a planned Nasdaq or NYSE public offering targeted for late 2026 or early 2027. Managed by Digital Offering, the raise allows accredited investors to participate in Parler’s rebuilt, fully sovereign technology ecosystem, which includes Triton Cloud, Edgecast CDN, PlayTV, Kyvo, Cartix, and ParlerNews operating on an integrated blockchain protocol layer. The company says its independent infrastructure significantly reduces operating costs and enhances creator earnings while enabling a unified creator-commerce platform designed to support…

Continue Reading

ThursdayDec 04, 2025 12:49 pm

NetworkNewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Aims to Close Homeownership Gap with Cutting-Edge Platform

Beeline Holdings (NASDAQ: BLNE) was featured in a recent article that discussed its fast-growing digital mortgage platform and the company’s efforts to redefine the path to homeownership. The piece reads “Its AI-enabled proprietary platform can scale loan processing volumes rapidly while maintaining operational efficiency. By automating much of the underwriting and documentation process, Beeline can approve loans within minutes and close them in as few as 14 to 21 days, less than half the industry average. The platform’s design also caters to a changing borrower demographic. According to National Mortgage Professional, only 26.1% of Gen Z and 54.9% of Millennials owned…

Continue Reading

ThursdayDec 04, 2025 11:45 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) identifies Biomarker Signature Predicting Sensitivity to IV Sapu003

Oncotelic Therapeutics (OTCQB: OTLC), reports that its 45% owned joint venture, Sapu Nano, has identified a High-RICTOR/Low-RPTOR molecular signature that predicts tumor sensitivity to Sapu003, the company’s intravenous Deciparticle(TM) formulation of everolimus. The biomarker framework, to be presented at the 2025 San Antonio Breast Cancer Symposium, is based on analysis of more than 9,000 tumor samples across 20 cancer types and represents the first prospective selection strategy for IV everolimus. Data show that mTORC2-dominant tumors — including HR+/HER2- breast, lung adenocarcinoma, gastric, renal, ovarian, AML and T-cell malignancies — exhibit heightened mTOR dependency and predicted sensitivity to Sapu003, which overcomes…

Continue Reading

ThursdayDec 04, 2025 11:34 am

NetworkNewsBreaks – MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Appoints Neil McMillan as Chairman of the Board 

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) has appointed longtime Saskatchewan resource and capital markets leader Neil McMillan as Chairman of the Board as the Company accelerates its Natural Hydrogen initiatives across the province. McMillan, former Chairman of Cameco and past President and CEO of Claude Resources, brings decades of financial, operational, and policy expertise at a pivotal stage for MAX Power, which has advanced early drilling success and a large permitted land position. Leadership says his expanded role strengthens governance and…

Continue Reading

ThursdayDec 04, 2025 9:59 am

NetworkNewsBreaks – VolitionRx (NYSE American: VNRX) Nu.Q NETs Assay Selected for France’s National Sepsis Detection Initiative

VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that its Nu.Q® NETs H3.1 assay has been chosen as the sole biomarker for “DETECSEPS,” a French government-funded evaluation of early sepsis detection under the France 2030 plan. The program, led by the IHU SEPSIS and supported by a €6.3 million (~$7.3 million) grant, aims to transform emergency care for patients with infection and risk of sepsis progression. Professor Djillali Annane, Intensive Care Department, IHU SEPSIS, Raymond Poincaré Hospital (AP-HP) and Scientific Director of DETECSEPS, noted that combining Volition’s Nu.Q® H3.1 biomarker with a clinical score (NEWS2) could improve…

Continue Reading

ThursdayDec 04, 2025 9:40 am

NetworkNewsBreaks – MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Featured in MiningNewsWire Editorial on Rising Energy Demand and Natural Hydrogen

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announces its inclusion in a MiningNewsWire editorial exploring how surging global electricity demand — driven by rapidly expanding AI and data-center power consumption — is creating urgent need for new baseload energy solutions. The article highlights natural hydrogen as a continuously generated, geologic energy source that could offer scalable, low-carbon support for AI-era power requirements. MAX Power is noted as the first publicly traded company in North America advancing a 1.3-million-acre land position permitted for…

Continue Reading

ThursdayDec 04, 2025 9:29 am

NetworkNewsBreaks – New Pacific Metals Corp. (TSX: NUAG) (NYSE American: NEWP) Reports Progress at Bolivian Silver Projects

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising.  New Pacific Metals (TSX: NUAG) (NYSE American: NEWP) reports continued advancement across its Carangas silver-gold project and Silver Sand silver project in Bolivia, noting strengthened community engagement, renewed government support for foreign investment, and steady progress toward permitting and development milestones. In 2025 the Company advanced the conversion of Carangas exploration licenses to administrative mining contracts, secured a favorable community vote to proceed with consultation activities, and began negotiating a long-term framework agreement. Work is also being planned for a feasibility study supported by…

Continue Reading